FabBenz Profile Banner
fabienne.benz Profile
fabienne.benz

@FabBenz

Followers
692
Following
509
Media
21
Statuses
209

Working on the spread of antibiotic-resistance plasmids and the role of plasmid-encoded CRISPR-Cas currently postdoc @institutpasteur previously phd @ETH

Paris, France
Joined May 2019
Don't wanna be here? Send us removal request.
@FabBenz
fabienne.benz
6 months
1/6 🚀 Delighted to see our review out online in Nature Reviews Bioengineering: CRISPR–Cas therapies targeting bacteria. Read:
nature.com
Nature Reviews Bioengineering - CRISPR–Cas tools can be designed to kill or modify specific bacteria. This Review explores the engineering of CRISPR–Cas tools and corresponding delivery...
@natrevbioeng
Nature Reviews Bioengineering
6 months
CRISPR–Cas therapies targeting bacteria https://t.co/Ug3IH6elQu
1
21
46
@BeatrizBeamud
Beatriz Beamud
6 months
Massive effort lead by the amazing @FabBenz to discuss the present and future of CRISPR-based antimicrobials ⚡
@natrevbioeng
Nature Reviews Bioengineering
6 months
CRISPR–Cas therapies targeting bacteria https://t.co/Ug3IH6elQu
1
5
20
@natrevbioeng
Nature Reviews Bioengineering
6 months
CRISPR–Cas therapies targeting bacteria https://t.co/Ug3IH6elQu
0
23
49
@FabBenz
fabienne.benz
6 months
ps this is my last post on X — you can find me on 💙 under fabbenz for plasmid eco-evo and CRISPRy subjects
0
0
1
@FabBenz
fabienne.benz
6 months
6/6 🙏 Huge thanks to co-authors @BeatrizBeamud @RaphaelLaurenceau @amandinemairee @duportet @AntoineDecrulle & @dbikard. 👏 Shout-out to the academics pushing the boundaries and to innovators at @sniprbiome , @LocusBio , @EligoBio and others turning concepts into clinics
1
0
0
@FabBenz
fabienne.benz
6 months
5/6 – Clinical opportunities 👩‍⚕️ First-in-human trials already show safety and efficacy—proof CRISPR therapeutics can work in humans!
1
0
0
@FabBenz
fabienne.benz
6 months
4/6 – The big hurdles 🛡️ Bacterial defences — restriction–modification systems, anti-CRISPRs and mutational escape — and how to bypass them
1
0
1
@FabBenz
fabienne.benz
6 months
3/6 – In-situ delivery 🚚 Engineered phages, conjugative plasmids & more — pros, cons, host range, cargo size and manufacturability. No one-size-fits-all!
1
0
1
@FabBenz
fabienne.benz
6 months
2/6 – CRISPR-Cas strategies 🧰 Toolbox & design considerations to eliminate bacteria or their plasmids — and to engineer microbes in situ
1
0
1
@IDDjobs
IDDjobs: infectious disease dynamics jobs
6 months
Two Postdocs (Lausanne, Switzerland) Bacterial genomics in the context of evolutionary epidemiology, with potential projects including antibiotic resistance, HGT and plasmid dynamics. with @sonjaklehtinen at University of Lausanne More details:
0
5
4
@FabBenz
fabienne.benz
10 months
Plasmid Biologists ‼️ ⚠️4 days left ⚠️ to sign up to join the #ISPB Virtual Seminar Series and submit your abstract for a talk. See you there 💥
@PlasmidSociety
International Society for Plasmid Biology (ISPB)
10 months
📢 Can’t wait until the 2026 meeting to dive deeper into plasmids? Join the ISPB Virtual Seminars Series, an exciting initiative aimed at strengthening our community in 2025! 🤓 📅 Registration and abstract submission open until 20th January: https://t.co/dByuAVZDCA
0
3
6
@FabBenz
fabienne.benz
11 months
The honor of being a 'Pasteurian' does not pay rent, certainly not in Paris… Fingers crossed for today's negotiations with @institutpasteur
1
0
1
@M_AresArroyo
Manuel Ares Arroyo
1 year
For the past two years, we have been working on a novel approach to identify origins of transfer by conjugation in plasmids from any bacterial species. We are thrilled to see this work now published in @NatureMicrobiol after thorough peer review! https://t.co/TpTxRy7jjd
Tweet card summary image
nature.com
Nature Microbiology - Characterization of known plasmid oriT features facilitates identification of 21 oriT-containing sequence families which, alongside candidate sequence validation, expands our...
10
66
170
@CCWendling
Carolin Wendling 
1 year
Fantastic PhD Opportunity on plasmid-phage interactions in Manchester with @c_igler and Mike Brockhurst👇also: the time in Germany would be spent in my lab
0
16
19
@PlasmidSociety
International Society for Plasmid Biology (ISPB)
1 year
Make sure you don't miss it! 🤓
@rafapinilla92
Rafa Pinilla-Redondo
1 year
Excited to share our last collab paper in @NatureComms on the structure & interference mechanism of the mysterious 𝗧𝘆𝗽𝗲 𝗜𝗩-𝗔 𝗖𝗥𝗜𝗦𝗣𝗥-𝗖𝗮𝘀 system!! 🧬🚀 🔗 https://t.co/kPzhs73Ffi 🧵 by @patrick_pausch below!
0
2
5
@Jana_Huisman
Jana S. Huisman
1 year
Should I stay or should I go? 🎶 In a new opinion piece, @c_igler, Andrina Bernhard and I discuss how conjugative plasmids and temperate bacteriophages balance vertical and horizontal transmission: https://t.co/ZEqTzsgDiV Our framework illuminates many sides of MGE biology (1/7)
1
26
47
@rafapinilla92
Rafa Pinilla-Redondo
1 year
1/8. 𝐧𝐜𝐑𝐍𝐀𝐬 often fly under the radar... but they're vital in bacteria-phage conflicts & beyond. Curious 𝙬𝙝𝙮!? 🤔 Here, we dive into their immune roles, plasticity, and discuss their hidden potential! 🧬🚀 🔗: https://t.co/XI5VANrMrI
1
57
198
@BruriaSamuel
Bruria Samuel
1 year
Meet The Shielded Plasmid🛡️🧬 Our new @Nature paper reveals how plasmids outsmart bacterial defenses during conjugation. It's all about being in the right place at the right time! The positioning of anti-defense genes boosts transfer efficiency🧵(1/7) https://t.co/6n8brUx1PU
17
124
345
@CCWendling
Carolin Wendling 
1 year
We are hiring! 1 PhD position available within our newly-funded @ERC_Research project #PHAGEPRO @LMU_Muenchen. We are looking for a candidate with a strong background in bioinformatics! ChatGPT-generated applications will not be considered. Watch👇to learn more about the project
@HelmholtzMunich
Helmholtz Munich | @HelmholtzMunich
1 year
ERC Starting Grant for PHAGE-PRO – Prof. Carolin Wendling🌟 @ERC_Research has awarded the project PHAGE-PRO with an #ERC Starting Grant. 🔎What is #PHAGE-PRO about? 👇Watch the video👇 👉 Prof. Carolin Wendling explains how PHAGE-PRO offers a novel approach to combating
2
104
207
@Celia_Sqe
Célia Souque
1 year
So glad to see this out! It was definitely a labor of love, but it has become my new blueprint of how I think about AMR evolution. We aimed to highlight how much we've learnt as a field, and especially, how much we still *don't* know 1/4
@baym
Michael Baym
1 year
Thrilled to see the first review article from my lab out in advance @AnnualReviews, helmed by @Celia_Sqe: From Petri Dishes to Patients to Populations: Scales and Evolutionary Mechanisms Driving Antibiotic Resistance https://t.co/doWuYeZAfb
3
19
97